MDR SUMMARY REPORTING COULD ELIMINATE 50,000 SUBMISSIONS PER YEAR, FDA ESTIMATES IN REENGINEERING PLAN; DISTRIBUTOR REPORTING TO BE ELIMINATED
This article was originally published in The Gray Sheet
The number of manufacturer adverse event reports submitted to FDA could be slashed by 50,000 a year through widespread use of summary reporting, the agency estimates.
You may also be interested in...
Top 100 Review: The Calm Before The Storm – But Some Medtechs Already Reflect The Ravages Of COVID-19
2019 saw fewer revenues-boosting major acquisitions by top-tier medtechs. Companies that reported after the calendar year-end were the first to see the consequences of the pandemic on their annual figures.
Hikma and Sesen Bio have struck a deal that will see Hikma distribute the Vicineum brand in the MENA region.
By establishing a dedicated consumer healthcare subsidiary, Norgine is hoping it can grow its $200m-plus Movicol laxative brand and take advantage of M&A opportunities in the OTC market.